Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
KT
KT
$8.83B
| $7.59M | 0.02% |
501,200
+30,217
| +6% | +$459K |
|
1002
Molina Healthcare
MOH
$10.8B
| $7.58M | 0.02% |
169,950
+105,955
| +166% | +$4.29M |
|
|
QUMU
1003
DELISTED
Qumu Corp.
QUMU
| $7.58M | 0.02% |
541,859
+15,100
| +3% | +$218K |
|
1004
Haemonetics
HAE
$4.11B
| $7.58M | 0.02% |
214,800
-39,426
| -16% | -$1.32M |
|
|
OKS
1005
DELISTED
Oneok Partners LP
OKS
| $7.58M | 0.02% |
129,300
-27,570
| -18% | -$1.54M |
|
|
TE
1006
DELISTED
TECO ENERGY INC
TE
| $7.55M | 0.02% |
408,600
-515,996
| -56% | -$9.07M |
|
1007
Aaon
AAON
$7.03B
| $7.52M | 0.02% |
504,873
+128,819
| +34% | +$1.72M |
|
|
OPEN
1008
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
| $7.51M | 0.02% |
+72,500
| New | +$5.53M |
|
|
WSTL
1009
DELISTED
Westell Technologies Inc
WSTL
| $7.5M | 0.02% |
765,755
+19,891
| +3% | +$232K |
|
1010
Greenlight Captial
GLRE
$505M
| $7.45M | 0.02% |
226,100
-24,005
| -10% | -$777K |
|
|
AMTG
1011
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $7.43M | 0.02% |
444,400
-76,722
| -15% | -$1.26M |
|
1012
Intercontinental Exchange
ICE
$85B
| $7.42M | 0.02% |
196,490
-524,295
| -73% | -$20.4M |
|
1013
Atlantic Union Bankshares
AUB
$6.09B
| $7.4M | 0.02% |
288,405
+55,000
| +24% | +$1.39M |
|
|
CSBK
1014
DELISTED
Clifton Bancorp Inc.
CSBK
| $7.38M | 0.02% |
582,849
+192,000
| +49% | +$2.29M |
|
1015
Arq
ARQ
$100M
| $7.36M | 0.02% |
321,100
-95,300
| -23% | -$2.12M |
|
1016
Bio-Rad Laboratories Class A
BIO
$9.68B
| $7.36M | 0.02% |
61,500
+31,730
| +107% | +$3.87M |
|
1017
FerroAtlántica
GSM
$818M
| $7.36M | 0.02% |
354,000
+46,374
| +15% | +$932K |
|
|
PAMT
1018
PAMT Corp
PAMT
$279M
| $7.35M | 0.02% |
1,052,000
+78,004
| +8% | +$472K |
|
1019
Information Services Group
III
$249M
| $7.32M | 0.02% |
1,521,394
+81,683
| +6% | +$404K |
|
|
XIN
1020
DELISTED
Xinyuan Real Estate
XIN
| $7.3M | 0.02% |
172,910
-13,420
| -7% | -$570K |
|
1021
Sun Life Financial
SLF
$44.4B
| $7.29M | 0.02% |
198,400
+14,275
| +8% | +$492K |
|
|
NUTR
1022
DELISTED
Nutraceutical International Co
NUTR
| $7.28M | 0.02% |
305,200
+10,022
| +3% | +$246K |
|
|
MEMP
1023
DELISTED
Memorial Production Partners LP Common Units
MEMP
| $7.28M | 0.02% |
300,150
-186,525
| -38% | -$4.26M |
|
1024
VF Corp
VFC
$5.73B
| $7.25M | 0.02% |
+122,236
| New | +$7.1M |
|
1025
Westwood Holdings Group
WHG
$183M
| $7.25M | 0.02% |
120,700
+8,200
| +7% | +$481K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.